NCT00253123 – A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone for Treatment of Behavioral Disturbances in Subjects With Dementia Posted on March 31, 2016 by tsuperadmin -
The efficacy and safety of flexible dose ranges of risperidone vs. Placebo or divalproex sodium in the treatment of manic or mixed episodes associated with bipolar 1 disorder Posted on March 31, 2016 by tsuperadmin -
NCT00257075 – The Efficacy And Safety Of Flexible Dosage Ranges Of Risperidone Versus Placebo In The Treatment Of Manic Episodes Associated With Bipolar I Disorder Posted on March 31, 2016 by tsuperadmin -
NCT00034762 – Efficacy And Safety Of A Flexible Dose Of Risperidone Versus Placebo In The Treatment Of Psychosis Of Alzheimer’s Disease Posted on March 31, 2016 by tsuperadmin -
A double-blind, placebo-controlled study of risperidone in children and adolescents with autistic disorder Posted on March 31, 2016 by tsuperadmin -
NCT00253136 – Risperidone Depot (Microspheres) vs. Placebo in the Treatment of Subjects With Schizophrenia Posted on March 31, 2016 by tsuperadmin -
NCT00253149 – The Safety And Efficacy Of Risperdal (Risperidone) Versus Placebo Versus Haloperidol As Add-On Therapy To Mood Stabilizers In The Treatment Of The Manic Phase Of Bipolar Disorder Posted on March 31, 2016 by tsuperadmin -
Risperidone versus haloperidol versus placebo in the treatment of schizophrenia Posted on March 31, 2016 by tsuperadmin -
NCT00088075 – A Randomized, Double-Blind, Placebo-Controlled Clinical Study of the Efficacy and Safety of Risperidone for the Treatment of Schizophrenia in Adolescents Posted on March 31, 2016 by tsuperadmin -
Efficacy and safety of a flexible dose of risperidone versus placebo in the treatment of psychosis of Alzheimer’s disease. A double-blind, placebo-controlled, parallel-group study. Posted on March 31, 2016 by tsuperadmin -